GOCM
PFE icon

Green Owl Capital Management’s Pfizer PFE Stock Holding History

Green Owl Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-28,300
Closed -$796K – 42
2016
Q1 		$796K Buy
+28,300
New +$808K 1.55% 21

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Green Owl Capital Management's PFE Position: Q2 2016 in Review

Green Owl Capital Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 28,300 shares — an estimated $796K sold.

Green Owl Capital Management first reported a position in PFE in Q1 2016 and held it in 1 quarter. The position peaked at $796K in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • Green Owl Capital Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
  • Green Owl Capital Management sold 28,300 Pfizer shares in Q2 2016, an estimated $796K.
  • Green Owl Capital Management first reported a position in Pfizer in Q1 2016 and held it in 1 quarter.
  • Green Owl Capital Management's Pfizer position peaked at $796K in Q1 2016.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Green Owl Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.